Apexigen’s corporate headquarters are located at 75 Shoreway Road, Suite C, San Carlos, CA 94070.
Apexigen is incorporated under the laws of the State of Delaware.
Apexigen is listed on The Nasdaq Global Select Market under the ticker symbol APGN. From February 22, 2021 to July 29, 2022, we traded under the ticker symbol BCAC.
Apexigen began trading on Nasdaq on February 22, 2021. From February 22, 2021 to July 29, 2022, we traded under the ticker symbol BCAC.
Apexigen’s fiscal year end is December 31.
Apexigen’s stock is available through The Nasdaq Global Select Market under the ticker symbol APGN.
Apexigen does not currently have a direct stock purchase plan. Apexigen’s stock may be purchased through a licensed securities broker.
Apexigen does not pay dividends.
Continental Stock Transfer & Trust Company
One State Street Plaza, 30th Floor
New York, NY 10004
For matters related to stock certificates, please contact Apexigen’s transfer agent:
Continental Stock Transfer & Trust Company
One State Street Plaza, 30th Floor
New York, NY 10004
You can visit the SEC Filings section of Apexigen’s Investor website or directly from the SEC’s website at https://www.sec.gov.
You can visit the Email Alerts section of Apexigen’s Investor website.
Moss Adams LLP
101 Second Street, Suite 900
San Francisco, CA 94105
Wilson Sonsini Goodrich & Rosati
650 Page Mill Road
Palo Alto, CA 94304
Please email Investor Relations at IR@Apexigen.com for assistance with other questions.